The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A multicenter, non-randomized, controlled trial to evaluate the efficacy of surgery versus radiofrequency ablation for small hepatocellular carcinoma (SURF-Cohort Trial): Analysis of overall survival.
 
Tatsuya Yamashita
Speakers' Bureau - Chugai Pharma; Eisai; Lilly; Sumitomo Dainippon Pharma Oncology; Takeda
 
Yoshikuni Kawaguchi
No Relationships to Disclose
 
Shuichi Kaneko
No Relationships to Disclose
 
Tadatoshi Takayama
No Relationships to Disclose
 
Namiki Izumi
No Relationships to Disclose
 
Naoki Yamanaka
No Relationships to Disclose
 
Masatoshi Kudo
Honoraria - Bayer; Bristol-Myers Squibb Japan; EA Pharma; Eisai; Lilly Japan; MSD
Consulting or Advisory Role - BMS; Eisai; MSD; Ono Pharmaceutical; Roche
Research Funding - Abbvie (Inst); EA Pharma (Inst); Eisai (Inst); Gilead Sciences (Inst); Ono Pharmaceutical; Otsuka (Inst); Sumitomo Dainippon (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst)
 
Mitsuo Shimada
Research Funding - Abbvie (Inst); Astellas Pharma (Inst); Bayer Yakuhin (Inst); Chugai Pharma (Inst); Covidien (Inst); EA Pharma (Inst); Eisai (Inst); Novartis (Inst); Ono Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst); TSUMURA & CO. (Inst)
 
Masafumi Inomata
No Relationships to Disclose
 
Hideo Baba
Honoraria - Ono Pharmaceutical
Research Funding - Asahi Kasei (Inst); Chugai Pharma (Inst); Eisai (Inst); Johnson & Johnson K.K. (Inst); Lilly Japan (Inst); Shin Nippon Biomedical (Inst); Taiho Pharmaceutical (Inst); Yakult Honsha (Inst)
 
Kazuhiko Koike
Speakers' Bureau - Bayer; Eisai
 
Masao Omata
No Relationships to Disclose
 
Masatoshi Makuuchi
No Relationships to Disclose
 
Yutaka Matsuyama
No Relationships to Disclose
 
Norihiro Kokudo
No Relationships to Disclose
 
Kiyoshi Hasegawa
Honoraria - Chugai Pharma; Eisai; Taiho Pharmaceutical; Takeda
Research Funding - Fujifilm (Inst); Nipro Corporation (Inst); Shimadzu (Inst)